Page 4 of 6

BI7.1-2 | Integration of Metabolism and Biological Oxidation — Part 3

The Chemiosmotic Theory of Peter Mitchell

Peter Mitchell's chemiosmotic hypothesis (1961, Nobel Prize 1978) has three core postulates:

Figure: The Chemiosmotic Theory of Peter Mitchell

Postulate 1: The ETC complexes pump protons from the matrix to the IMS. The inner mitochondrial membrane is impermeable to protons, so they accumulate on the IMS side, creating a proton-motive force (pmf). This is an electrochemical gradient — it has both a chemical component (ΔpH ≈ 0.5-1.0 pH units, IMS more acidic) and an electrical component (ΔΨ ≈ 150-180 mV, IMS positive). The total pmf ≈ 200 mV.

Postulate 2: ATP synthase uses the pmf to drive ATP synthesis. Protons flow back down their electrochemical gradient through ATP synthase — a molecular turbine embedded in the inner membrane. The energy of proton flow drives the phosphorylation of ADP + Pi → ATP. This is fundamentally different from substrate-level phosphorylation (which uses a high-energy substrate directly).

Postulate 3: The coupling between electron transport and ATP synthesis is indirect — mediated entirely by the pmf. There is no high-energy chemical intermediate linking the ETC to ATP synthase. The only connection is the proton gradient. This explains why uncouplers (which dissipate the gradient) can stimulate electron transport but abolish ATP synthesis.

Evidence supporting the theory: (1) Intact inner membrane is required — disrupted mitochondria can oxidise NADH but cannot make ATP; (2) The inner membrane is impermeable to H+ — this can be demonstrated experimentally; (3) The ETC generates a measurable ΔpH and ΔΨ across the inner membrane; (4) Uncouplers (like DNP) are lipid-soluble weak acids that carry H+ across the membrane, collapsing the gradient — this stimulates O2 consumption (ETC runs faster trying to maintain the gradient) but abolishes ATP synthesis; (5) Artificially creating a pH gradient across vesicles containing purified ATP synthase results in ATP synthesis (Racker and Stoeckenius, 1974 — the definitive experiment using bacteriorhodopsin + ATP synthase reconstituted into liposomes).

Figure: Evidence supporting the theory

The free energy of the pmf: Δp = ΔΨ − (2.303 RT/F) × ΔpH. At physiological conditions, Δp ≈ 200 mV. This is sufficient to drive ATP synthesis (ΔG for ATP synthesis ≈ +30.5 kJ/mol under standard conditions, but ≈ +50-54 kJ/mol under cellular conditions due to the mass action ratio).

Figure: The free energy of the pmf

ATP Synthase (Complex V) — The World's Smallest Rotary Motor

ATP synthase (F1F0-ATPase) is one of the most remarkable molecular machines in biology. It is a rotary motor — proton flow through the F0 component drives the physical rotation of a central shaft, which causes conformational changes in the F1 component that synthesise ATP.

Structure — Two functional units:

Figure: Structure — Two functional units

F0 (membrane-embedded, proton channel): Named for its sensitivity to oligomycin (an antibiotic that blocks the proton channel — "o" for oligomycin). Contains: (1) a c-ring — a ring of 8-15 c-subunits (varies by species; in humans, 8 c-subunits) embedded in the membrane; each c-subunit has a proton-binding site; (2) an a-subunit — contains two half-channels that allow protons to access the c-ring from the IMS (entry) and exit to the matrix; (3) a b-subunit — the stator stalk, connecting F0 to the alpha-beta hexamer of F1 (prevents F1 from spinning along with the rotor).

Figure: F0 (membrane-embedded, proton channel)

F1 (matrix-protruding, catalytic head): Contains: (1) an α3β3 hexamer — alternating alpha and beta subunits arranged like orange segments; the 3 beta subunits contain the catalytic sites for ATP synthesis; (2) a γ-subunit — the central rotating shaft (rotor), asymmetric, connected to the c-ring; (3) δ and ε subunits — connect γ to the c-ring and regulate activity.

Figure: F1 (matrix-protruding, catalytic head)

The binding change mechanism (Paul Boyer, Nobel Prize 1997): Each of the 3 β-subunits cycles through three conformations driven by the rotation of the γ-shaft: (1) O (Open) — low affinity, releases ATP; (2) L (Loose) — binds ADP + Pi loosely; (3) T (Tight) — binds substrates tightly and catalyses ATP formation (the actual phosphorylation step requires virtually no energy input; the energy is needed to release the tightly bound ATP). Each 120° rotation of γ advances all three sites by one step simultaneously. A full 360° rotation produces 3 ATP.

Stoichiometry and the P:O ratio: With 8 c-subunits in humans, 8 protons must flow through to complete one full rotation → 3 ATP. The actual H+/ATP ratio = 8/3 ≈ 2.67. But we must also account for the ATP/ADP translocase (ANT — exchanges matrix ATP4− for cytoplasmic ADP3−, consuming 1 ΔΨ unit) and the phosphate carrier (symports H2PO4− with H+, consuming 1 H+). So the effective cost = 2.67 + 1 = ~3.67 H+ per ATP exported to the cytoplasm. With 10 H+ pumped per NADH: 10 / 3.67 ≈ 2.5 ATP per NADH. With 6 H+ per FADH2: 6 / 3.67 ≈ 1.5 ATP per FADH2.

Figure: Stoichiometry and the P:O ratio

Total ATP yield from one glucose (revised values): Glycolysis: 2 ATP + 2 NADH (cytoplasmic — enters via malate-aspartate shuttle as mitochondrial NADH = 2 × 2.5 = 5 ATP, or glycerol-3-phosphate shuttle as FADH2 = 2 × 1.5 = 3 ATP). PDC: 2 NADH = 5 ATP. TCA (×2 turns): 6 NADH = 15 ATP + 2 FADH2 = 3 ATP + 2 GTP = 2 ATP. Total: 2 + 5 + 5 + 15 + 3 + 2 = 30-32 ATP per glucose (depending on the shuttle used for cytoplasmic NADH).

Figure: Total ATP yield from one glucose (revised values)

Uncoupling, Inhibitors, and Clinical Correlations

The tight coupling between electron transport and ATP synthesis can be disrupted in three ways: inhibition of the ETC, inhibition of ATP synthase, and uncoupling.

Figure: Uncoupling, Inhibitors, and Clinical Correlations

1. ETC Inhibitors — Block electron flow, which stops proton pumping, which stops ATP synthesis:
• Complex I: rotenone, barbiturates, metformin (mild), MPTP/MPP+
• Complex II: malonate (competitive inhibitor, succinate analogue), carboxin
• Complex III: antimycin A (Qi site), myxothiazol (Qo site)
• Complex IV: cyanide (CN−), carbon monoxide (CO), hydrogen sulphide (H2S), azide (N3−)
When the ETC is blocked, NADH/FADH2 cannot be reoxidised → NAD+ depleted → TCA cycle and beta-oxidation stop → cells rely on anaerobic glycolysis → lactate accumulates → lactic acidosis.

2. ATP Synthase Inhibitors — Block the proton channel, preventing H+ re-entry to the matrix:
• Oligomycin — binds the c-ring, blocking proton translocation. Result: the proton gradient builds up to maximum (no protons can flow back) → the gradient becomes so steep that the ETC can no longer pump against it → electron transport slows dramatically → O2 consumption drops. This is called respiratory control — the ETC is "controlled" by the availability of ADP (because without ATP synthesis, there is no ADP to phosphorylate, and protons cannot flow back through ATP synthase).

3. Uncouplers — Dissipate the proton gradient without going through ATP synthase:
Uncouplers are lipid-soluble weak acids that carry protons across the inner membrane, short-circuiting the gradient. The ETC runs at maximum speed (no gradient to pump against) but NO ATP is made. The energy is released as heat.

Chemical uncouplers:
• 2,4-Dinitrophenol (DNP) — historically used as a weight-loss pill (1930s); stimulates metabolism and generates heat. Causes fatal hyperthermia, profuse sweating, and death. Still available online; occasional poisoning cases reported in India.
• FCCP and CCCP — laboratory uncouplers used in mitochondrial research.
• Thermogenin (UCP1) — the physiological uncoupler. Found in brown adipose tissue (BAT), which is abundant in neonates and hibernating animals. UCP1 creates a proton leak in the inner membrane, generating heat for non-shivering thermogenesis. Indian neonates, especially in northern India, rely on BAT for thermoregulation in the first weeks of life. UCP1 is activated by free fatty acids and inhibited by purine nucleotides (GDP, GTP). Adults retain small amounts of BAT (supraclavicular, paravertebral regions) — this is an active area of obesity research. Other UCPs: UCP2 (widespread), UCP3 (skeletal muscle) — their exact roles are still debated.

4. Ionophores — Specific ion carriers that dissipate the ΔΨ or ΔpH:
• Valinomycin — carries K+ across the membrane, dissipating ΔΨ (the electrical component)
• Nigericin — exchanges K+ for H+, dissipating ΔpH (the chemical component) while maintaining ΔΨ

Mitochondrial diseases — Inherited defects in ETC complexes or mitochondrial DNA:
Because mitochondria have their own DNA (mtDNA, 37 genes, maternally inherited), mutations accumulate. Common syndromes: (1) MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes) — usually a Complex I mutation; (2) MERRF (Myoclonic Epilepsy with Ragged Red Fibres) — tRNA mutation affecting multiple complexes; (3) Leber's hereditary optic neuropathy (LHON) — Complex I mutation causing bilateral vision loss in young men; (4) Kearns-Sayre syndrome — large mtDNA deletion; progressive external ophthalmoplegia + cardiac conduction defects. Common features: lactic acidosis (cells shift to anaerobic glycolysis), ragged red fibres on muscle biopsy (accumulation of abnormal mitochondria), tissues with highest energy demand are most affected (brain, muscle, heart, retina, kidney).